Life Medical Gains IDE For Repel-CV Cardiovascular Anti-Adhesion Product
This article was originally published in The Gray Sheet
Executive Summary
Life Medical Sciences expects to have enough data gathered on its Repel-CV cardiovascular anti-adhesion product by the end of the year to support a humanitarian use device exemption.